SEOUL, April 23 (Korea Bizwire) – SK bioscience Co., the biopharmaceutical arm of South Korea’s SK Group, said Wednesday it has achieved a “final victory” in a patent invalidation case against Moderna, the global developer of the messenger-RNA (mRNA) COVID-19 vaccine. SK bioscience filed a nullity suit in 2023 challenging Moderna’s patent on modified nucleosides, [...]
SEOUL, April 23 (Korea Bizwire) — Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, said Wednesday its first-quarter net profit more than doubled from a year earlier, driven by expanded production and a weaker won. Net profit for the three months ended March surged to 375.6 billion won (US$263.9 million), up from [...]
SEOUL, April 22, (Korea Bizwire) — Intensifying competition from biosimilars and the looming expiration of lucrative drug patents have emerged as the foremost concerns for global pharmaceutical, biotech, and medical device companies, according to a 2025 report by Deloitte Korea. The report, titled “Five Key Challenges for the Global Pharmaceutical and Biotech Industry in 2025,” [...]
SEOUL, April 14 (Korea Bizwire) — Celltrion Inc., a major South Korean biopharmaceutical firm, said Monday it has obtained an interchangeability approval for its biosimilar drug for autoimmune disease treatment in the United States. The U.S. Food and Drug Administration (FDA) designated Celltrion’s biosimilar Yuflyma as interchangeable medicine for its original drug Humira in the [...]
SEOUL, April 4 (Korea Bizwire) — With patents on a wave of blockbuster drugs set to expire over the next five years, South Korea’s biopharmaceutical industry faces a critical window to capture a share of the rapidly expanding global contract development and manufacturing organization (CDMO) market, projected to be worth tens of trillions of won. [...]
SEOUL, April 4 (Korea Bizwire) — In a scientific breakthrough that could shape the next generation of vaccines and gene therapies, South Korean researchers have, for the first time, uncovered the precise mechanisms by which messenger RNA (mRNA) vaccines operate inside human cells. The discovery, published this week in the journal Science, comes from a team [...]
SEOUL, March 31 (Korea Bizwire) — South Korean pharmaceutical and biotech companies that surpassed 1 trillion won in annual revenue showed stark differences in operating efficiency, with employee productivity varying by as much as 19 times among industry leaders. According to industry data released March 30, nine companies joined the “trillion-won club” in 2024: Samsung Biologics, [...]
SEOUL, March 24 (Korea Bizwire) — Samsung E&A Co. said Monday it has secured a 518.6 billion-won (US$354.2 million) contract to build a biopharmaceutical raw material production and research facility in Songdo, west of Seoul, for Sartorius AG of Germany. The plant will be constructed for Sartorius Korea, the South Korean unit of the German [...]
SEOUL, March 24 (Korea Bizwire) — South Korean health authorities have reported a striking 140% increase in attention deficit hyperactivity disorder (ADHD) medication prescriptions over the past four years, while prescriptions for appetite suppressants continued their steady decline. According to data released by the Ministry of Food and Drug Safety, approximately 338,000 individuals received prescriptions for methylphenidate, [...]
SEOUL, March 20 (Korea Bizwire) – Pharmaceutical and biotech companies in South Korea are intensifying their efforts to diversify business operations, seeking to improve profitability and strengthen competitiveness by securing future growth engines. According to industry sources, ENCell, a company specializing in new drug development, plans to add artificial intelligence software development and services to its [...]